Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome

Primary Sjögren’s syndrome (pSS) is a systemic autoimmune rheumatic disease characterized by dryness of the eyes and mucous membranes, which can be accompanied by various extraglandular autoimmune manifestations. The majority of patients exhibit persistent systemic activation of the type I interfero...

Full description

Bibliographic Details
Main Authors: Erika Huijser, Marjan A. Versnel
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/3/532
_version_ 1797416767717376000
author Erika Huijser
Marjan A. Versnel
author_facet Erika Huijser
Marjan A. Versnel
author_sort Erika Huijser
collection DOAJ
description Primary Sjögren’s syndrome (pSS) is a systemic autoimmune rheumatic disease characterized by dryness of the eyes and mucous membranes, which can be accompanied by various extraglandular autoimmune manifestations. The majority of patients exhibit persistent systemic activation of the type I interferon (IFN) system, a feature that is shared with other systemic autoimmune diseases. Type I IFNs are integral to anti-viral immunity and are produced in response to stimulation of pattern recognition receptors, among which nucleic acid (NA) receptors. Dysregulated detection of endogenous NAs has been widely implicated in the pathogenesis of systemic autoimmune diseases. Stimulation of endosomal Toll-like receptors by NA-containing immune complexes are considered to contribute to the systemic type I IFN activation. Accumulating evidence suggest additional roles for cytosolic NA-sensing pathways in the pathogenesis of systemic autoimmune rheumatic diseases. In this review, we will provide an overview of the functions and signaling of intracellular RNA- and DNA-sensing receptors and summarize the evidence for a potential role of these receptors in the pathogenesis of pSS and the sustained systemic type I IFN activation.
first_indexed 2024-03-09T06:08:58Z
format Article
id doaj.art-f7998d1e89be4743920cd9db49dadae1
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T06:08:58Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-f7998d1e89be4743920cd9db49dadae12023-12-03T12:00:55ZengMDPI AGJournal of Clinical Medicine2077-03832021-02-0110353210.3390/jcm10030532Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s SyndromeErika Huijser0Marjan A. Versnel1Department of Immunology, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The NetherlandsDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The NetherlandsPrimary Sjögren’s syndrome (pSS) is a systemic autoimmune rheumatic disease characterized by dryness of the eyes and mucous membranes, which can be accompanied by various extraglandular autoimmune manifestations. The majority of patients exhibit persistent systemic activation of the type I interferon (IFN) system, a feature that is shared with other systemic autoimmune diseases. Type I IFNs are integral to anti-viral immunity and are produced in response to stimulation of pattern recognition receptors, among which nucleic acid (NA) receptors. Dysregulated detection of endogenous NAs has been widely implicated in the pathogenesis of systemic autoimmune diseases. Stimulation of endosomal Toll-like receptors by NA-containing immune complexes are considered to contribute to the systemic type I IFN activation. Accumulating evidence suggest additional roles for cytosolic NA-sensing pathways in the pathogenesis of systemic autoimmune rheumatic diseases. In this review, we will provide an overview of the functions and signaling of intracellular RNA- and DNA-sensing receptors and summarize the evidence for a potential role of these receptors in the pathogenesis of pSS and the sustained systemic type I IFN activation.https://www.mdpi.com/2077-0383/10/3/532Sjögren’s syndromeautoimmunecytosolic pattern recognition receptorsnucleic acid sensorsinterferon
spellingShingle Erika Huijser
Marjan A. Versnel
Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
Journal of Clinical Medicine
Sjögren’s syndrome
autoimmune
cytosolic pattern recognition receptors
nucleic acid sensors
interferon
title Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
title_full Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
title_fullStr Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
title_full_unstemmed Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
title_short Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
title_sort making sense of intracellular nucleic acid sensing in type i interferon activation in sjogren s syndrome
topic Sjögren’s syndrome
autoimmune
cytosolic pattern recognition receptors
nucleic acid sensors
interferon
url https://www.mdpi.com/2077-0383/10/3/532
work_keys_str_mv AT erikahuijser makingsenseofintracellularnucleicacidsensingintypeiinterferonactivationinsjogrenssyndrome
AT marjanaversnel makingsenseofintracellularnucleicacidsensingintypeiinterferonactivationinsjogrenssyndrome